[Experimental evidence for pharmacotherapy of cardiovascular and gastroduodenal diseases induced by the body's extreme exposures].
The results of examining the mechanisms of development of neurogenic visceral abnormalities induced by the body's extreme exposures, search for modes of its pharmacological correction are presented. Experiments have provided evidence for that the neutropic agents recovering the functional activity of the sympathetic nervous system, normalizing energy and plastic exchange have a positive effect in the treatment of the cardiovascular and gastroduodenal diseases which are caused by a neurogenic agent. A basically new approach to treating peptic ulcer, coronary heart diseases, and myocardial infarction is proposed depending on the stage of a disease.
Zavodskaia
I S
IS
Sapronov
N S
NS
Bul'on
V V
VV
Khnychenko
L K
LK
D001337:Autonomic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D004378:Duodenal Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006801:Humans; D018377:Neurotransmitter Agents / Q000378:metabolism; D013272:Stomach Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D013315:Stress, Psychological; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
D001337:Autonomic Agents; D018377:Neurotransmitter Agents
Eksperimental'noe obosnovanie farmakoterapii serdechno-sosudistoĭ i gastroduodenal'noĭ patologii, vyzvannoĭ ékstremal'nymi vozdeĭstviiami na organizm.